NEJM Retracts Landmark Avacopan Vasculitis Trial After Data Integrity Concerns

The New England Journal of Medicine has retracted a landmark 2021 trial on avacopan for ANCA-associated vasculitis following identification of…

Editor's Top Picks

Automated Genomic Reanalysis Tool Offers Rare Disease Diagnoses at Scale and Low Cost

Researchers have developed Talos, an open-source tool for automating reanalysis of genomic data from patients with rare genetic diseases, enabling…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

New R&D Ranking Reveals Sharp Disparities in Pharmaceutical Innovation Efficiency

A new evidence-based ranking of pharmaceutical companies reveals significant disparities in how efficiently firms convert R&D spending into drug approvals.…

New treatment approach offers hope for pre-eclampsia, a leading cause of maternal death

Pre-eclampsia causes more than 70,000 maternal deaths annually worldwide. Researchers are now investigating novel therapeutic approaches targeting placental dysfunction and…

Why Some Cancers Evade Chemotherapy: New Mechanism Identified

Researchers have identified a molecular mechanism that enables cancer cells to survive chemotherapy, revealing how 30–40% of treated tumors develop…

How Muscle Really Grows: Exercise Triggers Protein Synthesis, Not Just Microscopic Tears

Research now shows that muscle growth is driven primarily by elevated protein synthesis triggered by mechanical tension, not by microscopic…

GMJ BriefsView all →
© 2026 GMJ News · PHIG · Sheni Network